Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 75 citing Yue: Rosiglitazone treatment in Zucker diabetic fatty rats is associated with ameliorated.... (0.08 sec) 

Diabetic cardiomyopathy revisited


S Boudina, ED Abel - Circulation, 2007 - Am Heart Assoc
The prevalence of diabetes mellitus is growing rapidly. It is estimated that
globally the number of adults affected with diabetes will increase from 135
million in 1995 to 300 million by 2025. 1 Patients with diabetes mellitus ...
Cited by 136 - Related articles - All 5 versions

Peroxisome proliferator activated receptors as transcriptional nodal points and therapeutic …

- ahajournals.org
JD Brown, J Plutzky - Circulation, 2007 - Am Heart Assoc
Peroxisome proliferator–activated receptors (PPARs) are ligand-activated
transcription factors involved in the transcriptional regulation of key
metabolic pathways such as lipid metabolism, adipogenesis, and insulin ...
Cited by 104 - Related articles - All 8 versions

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

- nih.gov
RS Jope, CJ Yuskaitis, E Beurel - Neurochemical research, 2007 - Springer
Abstract Deciphering what governs inflammation and its effects on tissues is
vital for understanding many pathologies. The recent discovery that glycogen
synthase kinase-3 (GSK3) promotes inflammation reveals a new component of ...
Cited by 72 - Related articles - BL Direct - All 5 versions

Role of changes in cardiac metabolism in development of diabetic cardiomyopathy


D An, B Rodrigues - American Journal of Physiology- Heart and Circulatory …, 2006 - Am Physiological Soc
In patients with diabetes, an increased risk of symptomatic heart failure
usually develops in the presence of hypertension or ischemic heart disease.
However, a predisposition to heart failure might also reflect the effects ...
Cited by 66 - Related articles - BL Direct - All 5 versions

Small animal models of cardiovascular disease: tools for the study of the roles of metabolic …


JC Russell, SD Proctor - Cardiovascular pathology, 2006 - Elsevier
Cardiovascular disease, the leading cause of death in much of the modern world,
is the common symptomatic end stage of a number of distinct diseases and,
therefore, is multifactorial and polygenetic in character. The two major ...
Cited by 37 - Related articles - All 11 versions

Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and …

- physiology.org
Y Ye, Y Lin, S Atar, MH Huang, JR Perez-Polo … - American Journal of Physiology- Heart and Circulatory …, 2006 - Am Physiological Soc
We assessed 1) whether pretreatment before ischemia with pioglitazone (Pio)
limits infarct size (IS) and whether this protective effect is due to nitric
oxide synthase (NOS) and/or prostaglandin production, as has been shown for ...
Cited by 35 - Related articles - BL Direct - All 3 versions

Cardiac remodeling in obesity


ED Abel, SE Litwin, G Sweeney - Physiological Reviews, 2008 - Am Physiological Soc
The dramatic increase in the prevalence of obesity and its strong association
with cardiovascular disease have resulted in unprecedented interest in
understanding the effects of obesity on the cardiovascular system. A ...
Cited by 25 - Related articles - BL Direct - All 3 versions

Cardiac energy metabolism in obesity

- ahajournals.org
GD Lopaschuk, CDL Folmes, WC Stanley - Circulation Research, 2007 - Am Heart Assoc
Obesity results in marked alterations in cardiac energy metabolism, with a
prominent effect being an increase in fatty acid uptake and oxidation by the
heart. Obesity also results in dramatic changes in the release of ...
Cited by 24 - Related articles - All 16 versions

Physiological and pathological changes in glucose regulate brain Akt and glycogen …

- nih.gov
B Clodfelder-Miller, P De Sarno, AA … - Journal of Biological Chemistry, 2005 - ASBMB
Insulin regulates the phosphorylation and activities of Akt and glycogen
synthase kinase-3 (GSK3) in peripheral tissues, but in the brain it is less
clear how this signaling pathway is regulated in vivo and whether it is ...
Cited by 22 - Related articles - BL Direct - All 6 versions

How to revascularize patients with diabetes mellitus—


A Elsässer, H Möllmann, HM Nef, CW Hamm - Clinical Research in Cardiology, 2006 - Springer
Diabetes mellitus (DM) is a common illness with significant cardiovascular
importance. Recent esti- mates give a number of more than 150 million adults
worldwide suffering from DM [11]. Type 2 DM ac- counts for up to 95% of all ...
Cited by 16 - Related articles - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google